Companies / Contineum Therapeutics, Inc.
Contineum Therapeutics, Inc.
Nasdaq: CTNMCIK 1855175SAN DIEGO, CA
Financials · FY2024
Ownership
37.6M shares outstanding · as of Jul 24, 2026
Ownership
Share classes
| Class A | 87.61% | |
| Class B | 12.39% |
| Insiders | 0.04% | 14,954 |
| 10%+ / strategic | 5.00% | 1,879,367 |
| Institutions | 78.60% | 29,569,385 |
| Public float | 16.37% | 6,157,426 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Lorrain Daniel S.FormerChief Scientific Officer | 0.40% | 151,882 |
Stengone Carmine N.CEOCEO and President · Director | 0.04% | 14,954 |
Watkins TimFormerCMO & Head of Development | 0.00% | 0 |
Healy John StephenFormerGeneral Counsel and Corp Sec | — | — |
Slover Peter TChief Financial Officer | — | — |
Institutional holders 83
View all →| Holder | Value | % of shares |
|---|---|---|
| $35.59M | 7.27% | |
| $33.83M | 5.49% | |
| $32.48M | 7.55% | |
| $22.62M | 5.26% | |
| $22.01M | 4.48% | |
| $21.48M | 5.00% | |
| $20.05M | 4.08% | |
| $18.56M | 3.78% | |
| $16.93M | 3.44% | |
| $16.40M | 3.34% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Stengone Carmine N. CEO | Sell | Class A Common Stock | $70.5K | -4K -22.73% | 14,954 0.04% of shares | low |
| Feb 24, 2026 | Lorrain Daniel S. Executive | Sell | Class A Common Stock | $68.9K | -4K -2.68% | 156,052 0.41% of shares | low |
| Mar 2, 2026 | Lorrain Daniel S. Executive | Sell | Class A Common Stock | $62.6K | -4K -2.67% | 151,882 0.40% of shares | low |
| Feb 25, 2026 | Lorrain Daniel S. Executive | Sell | Class A Common Stock | $61.2K | -4K -2.39% | 156,052 0.41% of shares | low |
| Mar 2, 2026 | Watkins Tim Executive | Sell | Class A Common Stock | $54.2K | -4K -100.00% | 0 0.00% of shares | low |
| Feb 3, 2026 | Lorrain Daniel S. Executive | Sell | Class A Common Stock | $44.5K | -3K -1.87% | 157,222 0.42% of shares | low |
| Feb 25, 2026 | Stengone Carmine N. CEO | Sell | Class A Common Stock | $43.2K | -3K -15.29% | 14,954 0.04% of shares | low |
| Jan 28, 2026 | Watkins Tim Executive | Sell | Class A Common Stock | $39.4K | -3K -77.54% | 811 <0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Balyasny Asset Management L.P. | Passive13G | — |
| Janus Henderson Group PLC | Passive13G | — |
| RA Capital Management, L.P. | Passive13G/A | — |
| Franklin Resources, Inc. | Passive13G/A | — |
| Balyasny Asset Management L.P. | Passive13G | — |
| Millennium Management LLC | Passive13G | — |
| RA Capital Management, L.P. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CTNM | — | 21217B100 |